miR-1737 targets TAK1 to mediate the BMP-Smad signaling pathway to regulate the molecular mechanism of chicken tibial chondrodysplasia

miR-1737靶向TAK1,介导BMP-Smad信号通路,从而调控鸡胫骨软骨发育不良的分子机制

阅读:2
作者:Hengyong Xu,Ranran Du,Xiaojie Xie,Yuxiang Lu,Zhi Hu,Xuyang Ji,Longge Guo,Xinqi Wang,Yiping Liu,Zengrong Zhang,Yan Wang

Abstract

Tibial dyschondroplasia (TD) is a prevalent skeletal disorder in the modern broiler poultry industry. MicroRNAs (miRNAs) regulate various biological processes. Our previous studies suggest miR-1737 plays a role in cartilage development, but its mechanism in TD remains unclear. This study found that miR-1737 promotes chondrocyte proliferation and differentiation in TD chickens (P < 0.05), accelerating disease progression. Bioinformatics analysis predicted transforming growth factor β-activated kinase 1 (TAK1) as a target gene of miR-1737, which was confirmed through luciferase assays, qRT-PCR, and rescue experiments. TAK1 was shown to inhibit chondrocyte proliferation and differentiation (P < 0.05). Additionally, miR-1737 markedly upregulated the mRNA expression levels of Smad 1/5/8, key components of the BMP-Smad signaling pathway, and enhanced their phosphorylation, whereas TAK1 exhibited opposing effects. In conclusion, miR-1737 promotes TD chondrocyte proliferation and differentiation in vitro by targeting TAK1 and activating the BMP-Smad signaling pathway. These findings enhance our understanding of TD and suggest new molecular targets for its prevention and treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。